» Articles » PMID: 37117308

The Chemistry of Snake Venom and Its Medicinal Potential

Overview
Journal Nat Rev Chem
Publisher Springer Nature
Specialty Chemistry
Date 2023 Apr 28
PMID 37117308
Authors
Affiliations
Soon will be listed here.
Abstract

The fascination and fear of snakes dates back to time immemorial, with the first scientific treatise on snakebite envenoming, the Brooklyn Medical Papyrus, dating from ancient Egypt. Owing to their lethality, snakes have often been associated with images of perfidy, treachery and death. However, snakes did not always have such negative connotations. The curative capacity of venom has been known since antiquity, also making the snake a symbol of pharmacy and medicine. Today, there is renewed interest in pursuing snake-venom-based therapies. This Review focuses on the chemistry of snake venom and the potential for venom to be exploited for medicinal purposes in the development of drugs. The mixture of toxins that constitute snake venom is examined, focusing on the molecular structure, chemical reactivity and target recognition of the most bioactive toxins, from which bioactive drugs might be developed. The design and working mechanisms of snake-venom-derived drugs are illustrated, and the strategies by which toxins are transformed into therapeutics are analysed. Finally, the challenges in realizing the immense curative potential of snake venom are discussed, and chemical strategies by which a plethora of new drugs could be derived from snake venom are proposed.

Citing Articles

Metabolomics and proteomics: synergistic tools for understanding snake venom inhibition.

Hussain S, Kingsley J Arch Toxicol. 2025; 99(3):915-934.

PMID: 39760869 DOI: 10.1007/s00204-024-03947-4.


Beyond Fang's fury: a computational study of the enzyme-membrane interaction and catalytic pathway of the snake venom phospholipase A toxin.

Castro-Amorim J, Pinto A, Mukherjee A, Ramos M, Fernandes P Chem Sci. 2025; 16(4):1974-1985.

PMID: 39759936 PMC: 11694569. DOI: 10.1039/d4sc06511e.


Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system.

Zhong X, Wang C, Li Y, Zhang Q, Sun Q Heliyon. 2024; 10(10):e30969.

PMID: 38813202 PMC: 11133756. DOI: 10.1016/j.heliyon.2024.e30969.


Viper Venom Phospholipase A2 Database: The Structural and Functional Anatomy of a Primary Toxin in Envenomation.

de Oliveira A, Lacerda M, Ramos M, Fernandes P Toxins (Basel). 2024; 16(2).

PMID: 38393149 PMC: 10893444. DOI: 10.3390/toxins16020071.


Varying Modes of Selection Among Toxin Families in the Venoms of the Giant Desert Hairy Scorpions (Hadrurus).

Nystrom G, Ellsworth S, Ward M, Rokyta D J Mol Evol. 2023; 91(6):935-962.

PMID: 38091038 DOI: 10.1007/s00239-023-10148-7.


References
1.
Holford M, Daly M, King G, Norton R . Venoms to the rescue. Science. 2018; 361(6405):842-844. DOI: 10.1126/science.aau7761. View

2.
Casewell N, Wuster W, Vonk F, Harrison R, Fry B . Complex cocktails: the evolutionary novelty of venoms. Trends Ecol Evol. 2012; 28(4):219-29. DOI: 10.1016/j.tree.2012.10.020. View

3.
King G . Venoms as a platform for human drugs: translating toxins into therapeutics. Expert Opin Biol Ther. 2011; 11(11):1469-84. DOI: 10.1517/14712598.2011.621940. View

4.
Herzig V, Cristofori-Armstrong B, Israel M, Nixon S, Vetter I, King G . Animal toxins - Nature's evolutionary-refined toolkit for basic research and drug discovery. Biochem Pharmacol. 2020; 181:114096. PMC: 7290223. DOI: 10.1016/j.bcp.2020.114096. View

5.
Pineda S, Chin Y, Undheim E, Senff S, Mobli M, Dauly C . Structural venomics reveals evolution of a complex venom by duplication and diversification of an ancient peptide-encoding gene. Proc Natl Acad Sci U S A. 2020; 117(21):11399-11408. PMC: 7260951. DOI: 10.1073/pnas.1914536117. View